Cortagen

Cortagen is a bioregulatory peptide that acts primarily in the brain and central nervous system, helping to restore balance and normal function between pro-oxidant and anti-oxidant processes.

$15.90

WhatsApp us

Bulk price on WhatsApp!

MOQ: 10 pieces

Peptide manufacturing plant

Implementation of CGMP standards

ISO9001 & ISO14000

SHARE THIS
MOL
Product information navigation
What is Cortagen?

Cortagen (Ala-Glu-Asp-Pro) is one of the many “carvinson peptides”. These short peptides (typically only 2-4 amino acids in length) have powerful bioregulatory functions and are often found to alter tissue-specific patterns of gene expression.Cortagen, discovered by Vladimir Khavinson, acts primarily in the central nervous system, with secondary effects on the heart and immune system. Studies have shown that Cortagen stabilizes the inflammatory response in the central nervous system and helps promote a balance between pro- and anti-inflammatory pathways. Animal studies have shown that it reduces the long-term consequences of ischemic injury in the brain and helps restore neurological function after transection or injury.Cortagen is a geroprotective and anti-aging peptide. It helps restore DNA to a more youthful state, thereby reducing senescence and increasing the expression of certain genes that are silenced by age.

Studies have shown that gene expression patterns change with age. In particular, as DNA condenses from a more open euchromatin form to a denser heterochromatin form, overall gene expression levels tend to decrease. This condensation process inhibits DNA transcription factors from accessing certain genes and is one of the major contributors to the senescence process, a type of cellular aging. Studies have shown that peptide bioregulators can help reverse condensation and restore cells to a more youthful state [2].

Cortagen has significant effects on peripheral nerves as well as on structural and functional aspects of cardiac tissue. It is thought that this may be due to the uncondensation of chromatin structures. Scientists tested this hypothesis using transcriptome microarray analysis and found significant changes in 110 known genes distributed in over 234 different DNA regions [3].

In different experiments with similar goals, Cortagen was found to increase the activity of ribosomal genes and unravel chromatin protofibrils in a manner that releases genes repressed by age-specific chromatin condensation [4]. The same DNA uncoupling phenomenon occurs with other bioregulatory peptides, each with tissue-specific effects and few off-target effects [5].

In addition to altering DNA structure and reactivating dormant genes, Cortagen appears to affect aging by enhancing the body’s natural antioxidant mechanisms. Studies in rats have shown that Cortagen reduces the levels of LPO (lipid peroxidation) products. This reduces the amount of proteins affected by pathological oxidative processes and inhibits antioxidant activity in the blood and brain [6]. Lipid peroxidation (LPO) is a form of free radical-mediated tissue damage that particularly affects cell membranes in tissues with high lipid content. Lipids are abundant in the central nervous system and play a role in isolating nerves. Oxidation of these lipids leads to decreased nerve conductance and may contribute to neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease.

Collagen and nerve regeneration

Studies in rats have shown that intramuscular injection of 10 µg/kg Cortagen increased nerve fiber regeneration in the transverse curve by up to 40% [1]. This study suggests that surgical reattachment of damaged nerves and injection of Cortagen can actually help stimulate nerve repair and improve outcomes after severe spinal cord injury. This mechanism of action may be similar to the mechanism by which Cortagen 20mg promotes repair in the brain. It has long been known that the balance between pro-inflammatory and anti-inflammatory states helps to promote healing in other tissues, so it seems reasonable to assume that it has the same beneficial effect on the central nervous system.

Cortagen Summary

Cortagen is a bioregulatory peptide that acts primarily on the brain and central nervous system. It has secondary effects on the immune system and heart tissue. Studies have shown it to be a powerful modulator of inflammatory responses, especially in the nervous system, helping to restore balance and normal function between pro-oxidant and anti-oxidant processes. It has been studied as a potential treatment after ischemic brain injury, and it and similar compounds have shown beneficial long-term results.Cortagen stimulates IL-2 expression, helping to regulate immune function primarily by reducing autoimmune responses.

Structure
  • Sequence:Ala-Glu-Asp-Pro (AEDP)
  • CAS Number:/
  • Molecular Formula:C17H27N5O8
  • Molecular Weight: 430.17 g/mol
Referenced Citations
  1. L. N. Turchaninova, L. I. Kolosova, V. V. Malinin, A. B. Moiseeva, A. D. Nozdrachev, and V. K. Khavinson, “Effect of tetrapeptide cortagen on regeneration of sciatic nerve,” Bull. Exp. Biol. Med., vol. 130, no. 12, pp. 1172–1174, Dec. 2000.
  2. V. K. Khavinson, “Peptides and Ageing,” Neuro Endocrinol. Lett., vol. 23 Suppl 3, pp. 11–144, 2002.
  3. S. V. Anisimov, V. K. Khavinson, and V. N. Anisimov, “Elucidation of the effect of brain cortex tetrapeptide Cortagen on gene expression in mouse heart by microarray,” Neuro Endocrinol. Lett., vol. 25, no. 1–2, pp. 87–93, Apr. 2004.
  4. V. K. Khavinson, T. A. Lezhava, and V. V. Malinin, “Effects of short peptides on lymphocyte chromatin in senile subjects,” Bull. Exp. Biol. Med., vol. 137, no. 1, pp. 78–81, Jan. 2004, doi: 10.1023/b:bebm.0000024393.40560.05.
  5. T. Lezhava, J. Monaselidze, T. Kadotani, N. Dvalishvili, and T. Buadze, “Anti-aging peptide bioregulators induce reactivation of chromatin,” Georgian Med. News, no. 133, pp. 111–115, Apr. 2006.
  6. L. S. Kozina, “Effects of bioactive tetrapeptides on free-radical processes,” Bull. Exp. Biol. Med., vol. 143, no. 6, pp. 744–746, Jun. 2007, doi: 10.1007/s10517-007-0230-8.
  7. A. V. Gumen, I. A. Kozinets, S. N. Shanin, V. V. Malinin, and E. G. Rybakina, “Production of lymphocyte-activating factors by mouse macrophages during aging and under the effect of short peptides,” Bull. Exp. Biol. Med., vol. 142, no. 3, pp. 360–362, Sep. 2006, doi: 10.1007/s10517-006-0366-y.
  8. T. B. Kazakova et al., “In vitro effect of short peptides on expression of interleukin-2 gene in splenocytes,” Bull. Exp. Biol. Med., vol. 133, no. 6, pp. 614–616, Jun. 2002, doi: 10.1023/a:1020210615148.
  9. I. V. Zarubina and P. D. Shabanov, “[Cortexin and cortagen as correcting agents in functional and metabolic disorders in the brain in chronic ischemia],” Eksp. Klin. Farmakol., vol. 74, no. 2, pp. 8–15, 2011.
  10. N. V. Gulyaeva, “[Molecular mechanisms of brain peptide-containing drugs: cortexin],” Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova, vol. 118, no. 10, pp. 93–96, 2018, doi: 10.17116/jnevro201811810193.
  11. D. V. Kurkin et al., “Neuroprotective action of Cortexin, Cerebrolysin and Actovegin in acute or chronic brain ischemia in rats,” PloS One, vol. 16, no. 7, p. e0254493, 2021, doi: 10.1371/journal.pone.0254493.

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATONAL AND EDUCATIONAL PURPOSES ONLY.

In no way does this doctor/scientist endorse or advocate the purchase, sale, or use of this product for any reason. MOL Changes has no affiliation or relationship, implied or otherwise, with this physician. The purpose of citing this doctor is to acknowledge, acknowledge and commend the exhaustive research and development work done by the scientists working on this peptide.

Manufacturer Information

  • Cortagen is manufactured by MOL Changes factory.
  • Cortagen supplier MOL Changes.
  • Maximum acceptable production volume: 10,000 bottles.
  • Content standard: net peptide.
  • Purity: ≥98% for all products.
  • Customization: 1mg-1g size customization is acceptable
en_USEnglish